• Mashup Score: 0

    Derek Kang joins Alicia Morgans to discuss an ongoing exercise study focused on Black patients with prostate cancer undergoing Androgen Deprivation Therapy. This groundbreaking project is designed to study the potential effects of regular exercise on these patients’ physical function, metabolic health, and prostate cancer outcomes. The study hopes to mitigate the higher risk of cardiovascular…

    Tweet Tweets with this article
    • Harnessing exercise to improve outcomes in Black #ProstateCancer patients. @DKang_PhD @DanaFarber joins @CaPsurvivorship to discuss an ongoing #exercise study focused on Black patients with #PCa undergoing androgen deprivation therapy #ADT > https://t.co/ubWu5CBcqU https://t.co/SdIeYezqCL

  • Mashup Score: 0

    Derek Kang joins Alicia Morgans to discuss an ongoing exercise study focused on Black patients with prostate cancer undergoing Androgen Deprivation Therapy. This groundbreaking project is designed to study the potential effects of regular exercise on these patients’ physical function, metabolic health, and prostate cancer outcomes. The study hopes to mitigate the higher risk of cardiovascular…

    Tweet Tweets with this article
    • Harnessing exercise to improve outcomes in Black #ProstateCancer patients. @DKang_PhD @DanaFarber joins @CaPsurvivorship to discuss an ongoing #exercise study focused on Black patients with #PCa undergoing androgen deprivation therapy #ADT > https://t.co/ubWu5CBcqU https://t.co/Gm0WWsIjJ7

  • Mashup Score: 0

    Derek Kang joins Alicia Morgans to discuss an ongoing exercise study focused on Black patients with prostate cancer undergoing Androgen Deprivation Therapy. This groundbreaking project is designed to study the potential effects of regular exercise on these patients’ physical function, metabolic health, and prostate cancer outcomes. The study hopes to mitigate the higher risk of cardiovascular…

    Tweet Tweets with this article
    • Harnessing exercise to improve outcomes in Black #ProstateCancer patients. @DKang_PhD @DanaFarber joins @CaPsurvivorship to discuss an ongoing #exercise study focused on Black patients with #PCa undergoing androgen deprivation therapy #ADT > https://t.co/ubWu5CBcqU https://t.co/hrMaAJtxSQ

  • Mashup Score: 0

    Derek Kang joins Alicia Morgans to discuss an ongoing exercise study focused on Black patients with prostate cancer undergoing Androgen Deprivation Therapy. This groundbreaking project is designed to study the potential effects of regular exercise on these patients’ physical function, metabolic health, and prostate cancer outcomes. The study hopes to mitigate the higher risk of cardiovascular…

    Tweet Tweets with this article
    • Harnessing exercise to improve outcomes in Black #ProstateCancer patients. @DKang_PhD @DanaFarber joins @CaPsurvivorship to discuss an ongoing #exercise study focused on Black patients with #PCa undergoing androgen deprivation therapy #ADT > https://t.co/ubWu5CBcqU https://t.co/kkUAcHWKrz

  • Mashup Score: 3

    Daniel Spratt, MD, reviews the data from two trials that demonstrate the selection of patients for the addition of hormone therapy (ADT) to post-prostatectomy radiation therapy. Dr. Spratt discusses two phase three trials that have evaluated hormonal therapy in the postoperative RP setting with a rising PSA. The RTOG 9601 trial and the GETUG-AFU 16 trial are distinct from each other where the…

    Tweet Tweets with this article
    • When to add #ADT to early or late salvage radiation. @DrSpratticus @caseccc reviews data from two trials demonstrating the selection of pts for the addition of hormone therapy to post-prostatectomy RT > https://t.co/zDyaNeGBh7 @Decipher_VCYT @ashleyrossmdphd @a_dalpra https://t.co/zUuNgO7JKr

  • Mashup Score: 3
    Wolters Kluwer Health - 1 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Data from the Phase III ARASENS trial showed darolutamide plus #ADT and docetaxel led to an overall #survival benefit over placebo plus ADT and docetaxel in Black/African American patients with metastatic hormone-sensitive #ProstateCancer #mHSPC: https://t.co/ShKggTj3N5 https://t.co/JeyubP9jv0